Inventor · disambiguated record
Chen Mao
Also filed as: MAO CHEN · MAO CHEN SHOW
31 granted patents·14 pending applications·92 citations·filing 1997–2024
96Inventor score
Files withPARKER HUGHES INST12XENOPORT INC11GENENTECH INC6VIVA BIOTECH (SHANGHAI) LTD4ARBOR PHARMACEUTICALS LLC3
Top patents by PatentIndex Score
45 records- 0186US6329420B1Tubulin binding compounds (COBRA)PARKER HUGHES INST·Filed 2000·Granted Dec 11, 2001·11 cites·10 claims
- 0285US10716760B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2016·Granted Jul 21, 2020·2 cites·18 claims
- 0385US2025109136A1Dosage form compositions comprising an inhibitor of bruton's tyrosine kinaseGENENTECH INC·Filed 2024·Application pending·0 cites
- 0483US9421182B2Cocrystals of dimethyl fumarateXENOPORT INC·Filed 2014·Granted Aug 23, 2016·2 cites·10 claims
- 0583US8399513B2Levodopa prodrug mesylate hydrateKARABORNI SAMI·Filed 2009·Granted Mar 19, 2013·4 cites·24 claims
- 0682US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 0777US2023339957A1Dosage form compositions comprising an inhibitor of bruton's tyrosine kinaseGENENTECH INC·Filed 2023·Application pending·0 cites
- 0876US10246461B2Dosage form compositions comprising an inhibitor of bruton's tyrosine kinaseGENENTECH INC·Filed 2017·Granted Apr 2, 2019·2 cites·11 claims
- 0975US6258841B1Tubulin binding compounds (COBRA)PARKER HUGHES INST·Filed 1999·Granted Jul 10, 2001·14 cites·14 claims
- 1073US9416096B2Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useXENOPORT INC·Filed 2014·Granted Aug 16, 2016·1 cites·19 claims
- 1173US2022267340A1Dosage form compositions comprising an inhibitor of bruton's tyrosine kinaseGENENTECH INC·Filed 2022·Application pending·0 cites
- 1272US6512003B2Synthetic spiroketal pyranes as potent anti-cancer agents and usePARKER HUGHES INST·Filed 2001·Granted Jan 28, 2003·4 cites·38 claims
- 1372US6335364B1Synthetic spiroketal pyranes as potent anti-cancer agentsPARKER HUGHES INST·Filed 1999·Granted Jan 1, 2002·11 cites·17 claims
- 1471US2024197661A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1570US5998411AHeterocyclic nonnucleoside inhibitors of reverse transcriptaseHUGHES INST·Filed 1998·Granted Dec 7, 1999·15 cites·26 claims
- 1670US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1767US11365197B2Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinaseGENENTECH INC·Filed 2020·Granted Jun 21, 2022·0 cites·22 claims
- 1866US6380190B1Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererofPARKER HUGHES INST·Filed 2001·Granted Apr 30, 2002·1 cites·13 claims
- 1966US6300351B1Beta-fluoroethyl thiourea compounds and usePARKER HUGHES INST·Filed 2000·Granted Oct 9, 2001·1 cites·12 claims
- 2063US2025000802A1Solid formulations comprising an inhibitor of the k-ras protein having a g12c mutation, and a process for preparingHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2162US8722733B2Levodopa prodrug mesylate hydrateXENOPORT INC·Filed 2013·Granted May 13, 2014·0 cites·19 claims
- 2261US9895336B2Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useXENOPORT INC·Filed 2017·Granted Feb 20, 2018·0 cites·11 claims
- 2361US9795581B2Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useXENOPORT INC·Filed 2017·Granted Oct 24, 2017·0 cites·14 claims
- 2461US9597292B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2013·Granted Mar 21, 2017·0 cites·4 claims
- 2561US2020000758A1Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs ThereofXENOPORT INC·Filed 2019·Application pending·0 cites
- 2660US9682057B2Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and useXENOPORT INC·Filed 2016·Granted Jun 20, 2017·0 cites·11 claims
- 2760US2005153995A1Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereofPARKER HUGHES INST·Filed 2004·Application pending·0 cites
- 2860US2019177331A1Dosage form compositions comprising an inhibitor of bruton's tyrosine kinaseGENENTECH INC·Filed 2019·Application pending·0 cites
- 2956US8435562B2Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of useMAO CHEN·Filed 2010·Granted May 7, 2013·1 cites·21 claims
- 3055US10221231B2Method of expressing a G-protein coupled receptor proteinVIVA BIOTECH SHANGHAI LTD·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 3155US10106595B2Nucleic acid sequence encoding a fusion proteinVIVA BIOTECH SHANGHAI LTD·Filed 2017·Granted Oct 23, 2018·0 cites·5 claims
- 3255US2015079180A1Nanoparticle compositions of dimethyl fumarateXENOPORT INC·Filed 2014·Application pending·0 cites
- 3352US7919505B2Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compoundSCHERING CORP·Filed 2007·Granted Apr 5, 2011·0 cites·44 claims
- 3451US9670252B2Fusion expression of G-protein coupled receptorVIVA BIOTECH (SHANGHAI) LTD·Filed 2015·Granted Jun 6, 2017·0 cites·3 claims
- 3549US2005096473A1Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis inductionPARKER HUGHES INST·Filed 2004·Application pending·0 cites
- 3647US2002045764A1Tubulin binding compounds (COBRA)PARKER HUGHES INST·Filed 2001·Application pending·0 cites
- 3745US6156759ANonnucleoside inhibitors of reverse transcriptase, composite binding pocket and method for use thereofPARKER HUGHES INST·Filed 1998·Granted Dec 5, 2000·1 cites·9 claims
- 3845US6124307ANonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereofWAYNE HUGHES INST·Filed 1998·Granted Sep 26, 2000·4 cites·11 claims
- 3945US5806638APull rod base of luggageFiled 1997·Granted Sep 15, 1998·16 cites·3 claims
- 4044US6794541B2Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis inductionPARKER HUGHES INST·Filed 2001·Granted Sep 21, 2004·0 cites·1 claims
- 4143US2015157590A9Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioateXENOPORT INC·Filed 2013·Application pending·0 cites
- 4237US6925388B1Heterocyclic nonnucleoside inhibitors of reverse transcriptasePARKER HUGHES INST·Filed 1998·Granted Aug 2, 2005·0 cites·17 claims
- 4337US6180654B1Heterocyclic nonnucleoside inhibitors of reverse transcriptaseWAYNE HUGHES INST·Filed 1998·Granted Jan 30, 2001·1 cites·20 claims
- 4436US2017159096A1Method for fusion expression of ion channel protein and transport protein and protein fragment used thereforVIVA BIOTECH (SHANGHAI) LTD·Filed 2016·Application pending·0 cites
- 4530US9920022B2Small molecule compound and synthesizing method and uses thereofTECHNODERMA MEDICINES PTE LTD·Filed 2017·Granted Mar 20, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Chen Mao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →